315 related articles for article (PubMed ID: 24861265)
1. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
Africander DJ; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
[TBL] [Abstract][Full Text] [Related]
2. Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy.
Africander D; Louw R; Hapgood JP
Biochem Biophys Res Commun; 2013 Apr; 433(3):305-10. PubMed ID: 23473756
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.
Africander D; Louw R; Verhoog N; Noeth D; Hapgood JP
Contraception; 2011 Oct; 84(4):423-35. PubMed ID: 21920200
[TBL] [Abstract][Full Text] [Related]
4. Synthetic progestins used in HRT have different glucocorticoid agonist properties.
Koubovec D; Ronacher K; Stubsrud E; Louw A; Hapgood JP
Mol Cell Endocrinol; 2005 Oct; 242(1-2):23-32. PubMed ID: 16125839
[TBL] [Abstract][Full Text] [Related]
5. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.
Ochnik AM; Moore NL; Jankovic-Karasoulos T; Bianco-Miotto T; Ryan NK; Thomas MR; Birrell SN; Butler LM; Tilley WD; Hickey TE
Menopause; 2014 Jan; 21(1):79-88. PubMed ID: 23715406
[TBL] [Abstract][Full Text] [Related]
6. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
Buchanan G; Birrell SN; Peters AA; Bianco-Miotto T; Ramsay K; Cops EJ; Yang M; Harris JM; Simila HA; Moore NL; Bentel JM; Ricciardelli C; Horsfall DJ; Butler LM; Tilley WD
Cancer Res; 2005 Sep; 65(18):8487-96. PubMed ID: 16166329
[TBL] [Abstract][Full Text] [Related]
7. Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.
Hapgood JP; Ray RM; Govender Y; Avenant C; Tomasicchio M
Am J Reprod Immunol; 2014 Jun; 71(6):505-12. PubMed ID: 24547700
[TBL] [Abstract][Full Text] [Related]
8. Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Δ(4)-tibolone.
Bianco-Miotto T; Trotta AP; Need EF; Lee AM; Ochnik AM; Giorgio L; Leach DA; Swinstead EE; O'Loughlin MA; Newman MR; Birrell SN; Butler LM; Harris JM; Buchanan G
Mol Cell Endocrinol; 2014 Feb; 382(2):899-908. PubMed ID: 24239616
[TBL] [Abstract][Full Text] [Related]
9. The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.
Ghatge RP; Jacobsen BM; Schittone SA; Horwitz KB
Breast Cancer Res; 2005; 7(6):R1036-50. PubMed ID: 16457685
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins.
García-Becerra R; Cooney AJ; Borja-Cacho E; Lemus AE; Pérez-Palacios G; Larrea F
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):21-7. PubMed ID: 15261304
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
[TBL] [Abstract][Full Text] [Related]
12. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.
Govender Y; Avenant C; Verhoog NJ; Ray RM; Grantham NJ; Africander D; Hapgood JP
PLoS One; 2014; 9(5):e96497. PubMed ID: 24840644
[TBL] [Abstract][Full Text] [Related]
13. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
Louw-du Toit R; Perkins MS; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2017 Sep; 491(1):140-146. PubMed ID: 28711501
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
15. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.
Tomasicchio M; Avenant C; Du Toit A; Ray RM; Hapgood JP
PLoS One; 2013; 8(5):e62895. PubMed ID: 23658782
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
[TBL] [Abstract][Full Text] [Related]
17. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
Moore NL; Buchanan G; Harris JM; Selth LA; Bianco-Miotto T; Hanson AR; Birrell SN; Butler LM; Hickey TE; Tilley WD
Endocr Relat Cancer; 2012 Aug; 19(4):599-613. PubMed ID: 22719059
[TBL] [Abstract][Full Text] [Related]
18. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
19. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
Seeger H; Rakov V; Mueck AO
Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
